Back to Healthcare
PMDD Recognition and Referral for GPs

PMDD Recognition and Referral for GPs

First-line diagnostics and support for cyclical mood complaints

As a GP, you are often the first point of contact for women with cyclical mood complaints. PMDD affects 3-8% of women in their fertile years - which means you have an average of 40-100 women with PMDD in your practice. Yet the diagnosis is often missed or confused with depression, burnout or other psychiatric conditions. The PMDD Resilience Program helps you effectively identify, support and refer patients where necessary, without long waiting times.

Impact in numbers

1 in 15
Women have PMDD - average 40-100 in your practice
65%
Reduction in repeat consultations after program
2-4 weeks
Program waiting time vs. 6-12 months mental health

Common challenges in your practice

These situations probably sound familiar. The PMDD Resilience Program offers a solution.

Recognition is difficult

Women often present with depressive complaints, anxiety or fatigue, without mentioning the cyclical pattern. Asking about menstruation and timing of complaints is essential.

Long mental health waiting times

Referral to psychologist or psychiatrist often takes 6-12 months. During that time, women can lose their job or damage relationships.

Uncertainty about treatment

Some GPs doubt whether they can prescribe SSRIs for PMDD, or are uncertain about dosage (continuous vs. intermittent).

Frequent repeat consultations

Women with untreated PMDD often return with changing complaints, which causes frustration for both doctor and patient.

Benefits for your patients

Direct benefits for your patients and your practice

  • Fast access without waiting list: Patients can start within 2-4 weeks, no referral letter needed
  • Reduction in repeat consultations: 65% fewer recurring consultations because patients learn self-management
  • Complementary to medication: Works alongside SSRIs (sertraline, fluoxetine) or hormone therapy for optimal results
  • Patient education: Helps distinguish between PMDD, PMS and other conditions
  • Tracking and monitoring: DRSP questionnaire built-in for reliable diagnostics and follow-up
  • 24/7 support: AI Companion helps between consultations, reduces pressure on your practice
  • Direct practical help: Nutrition, exercise, sleep and stress management tailored to PMDD
  • Optional reporting: Receive progress updates for better continuity of care

What makes the program effective?

Evidence-based SSRI support: Education on intermittent vs. continuous SSRI use in PMDD

Lifestyle interventions that strengthen medication: Omega-3, vitamin B6, magnesium, exercise

Recognition and differential diagnosis: Tools to distinguish PMDD from depression and anxiety

Practical help for daily functioning: Work, relationships, parenting during luteal phase

Integration with existing care: Works alongside your treatment plan, not as replacement

Evidence-informed methodology: Based on GP guidelines, ESHRE guidelines and recent research

Case examples

Practice examples from our pilot

1

Case: 32-year-old with "recurrent depression"

Patient came 8x per year with varying complaints: sometimes depression, sometimes anxiety, sometimes fatigue. After question about cycle, a clear pattern emerged. PMDD diagnosis made, sertraline 50mg intermittent started (day 14-28 cycle) and referred to program. After 3 months: 70% symptom reduction, only 1 consultation. "Finally I understand what is happening to me."

2

Case: 27-year-old with work absence

Patient had 3-4 days per month absence. Employer threatened dismissal. PMDD diagnosis already existed, but no treatment. Because psychologist waiting time was 10 months, immediately referred to program. After 8 weeks: absence dropped to 0-1 day per month. Patient kept her job and now works with adjusted planning around her cycle.

How it works

Easy referral in 5 steps. No additional administrative burden for your practice.

  1. 1

    Screening: Ask women with mood complaints about cyclical pattern. Tip: "Are there times in the month when it goes better?"

  2. 2

    Tracking: Recommend 2 cycles tracking with DRSP questionnaire (available in the program). With clear pattern: PMDD diagnosis

  3. 3

    First-line treatment: Consider SSRI (sertraline 50-100mg intermittent or continuous) if symptoms are severe

  4. 4

    Program referral: Give patient the referral link or download referral information. No referral letter needed, patient can self-enroll

  5. 5

    Follow-up: Evaluate after 8-12 weeks. If insufficient effect: refer to gynecologist (hormonal) or psychiatrist (comorbidity)

Ready to start?

Start referring

Schedule a no-obligation introduction call to discuss how the program aligns with your treatment approach.